Clinical Trial
Combined vaccine against measles, mumps, rubella, and varicella
Affiliations
- PMID: 2835743
Item in Clipboard
Clinical Trial
Combined vaccine against measles, mumps, rubella, and varicella
Pediatrics.
1988 Jun.
Abstract
A combined measles, mumps, rubella, and varicella vaccine produced seroconversions for all four components similar to that found if measles, mumps, and rubella vaccine or live varicella vaccine were given separately. In addition, those exposed to varicella were completely protected or had only a mild rash. Moreover, the reaction rates were not increased if the vaccines were combined. The somewhat lower and delayed serologic response to live varicella vaccine as compared with the combined measles, mumps, rubella, and varicella may have been due to the small amount of varicella vaccine virus used or to its degree of attenuation. Persistence of antibody was observed 1 year postimmunization.
Similar articles
-
The combination measles, mumps, rubella and varicella vaccine in healthy children.Dev Biol Stand. 1986;65:89-93. Dev Biol Stand. 1986. PMID: 3030864 Clinical Trial.
-
Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.Pediatrics. 1994 Oct;94(4 Pt 1):514-6. Pediatrics. 1994. PMID: 7936862 Clinical Trial.
-
Combination measles, mumps, rubella and varicella vaccine.Pediatrics. 1986 Oct;78(4 Pt 2):742-7. Pediatrics. 1986. PMID: 3763291 Clinical Trial.
-
[Duration of immunity and occurrence of secondary vaccine failure following vaccination against measles, mumps and rubella].Ugeskr Laeger. 1992 Jul 13;154(29):2008-13. Ugeskr Laeger. 1992. PMID: 1509566 Review. Danish.
-
Two doses of MMR vaccine--sufficient to eradicate measles, mumps and rubella?Scand J Soc Med. 1988;16(3):129-35. doi: 10.1177/140349488801600301. Scand J Soc Med. 1988. PMID: 3057621 Review.
Cited by
-
Varicella vaccine update.West J Med. 1988 Oct;149(4):450. West J Med. 1988. PMID: 18750478 Free PMC article. No abstract available.
-
Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data.Vaccine. 2013 Mar 25;31(13):1680-94. doi: 10.1016/j.vaccine.2012.05.050. Epub 2012 Jun 1. Vaccine. 2013. PMID: 22659447 Free PMC article. Review.
-
The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka).J Virol. 1990 Sep;64(9):4540-8. doi: 10.1128/JVI.64.9.4540-4548.1990. J Virol. 1990. PMID: 2166829 Free PMC article.
-
Measles control in the United States: problems of the past and challenges for the future.Clin Microbiol Rev. 1995 Apr;8(2):260-7. doi: 10.1128/CMR.8.2.260. Clin Microbiol Rev. 1995. PMID: 7621401 Free PMC article. Review.
-
Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.Cochrane Database Syst Rev. 2014 Jun 23;2014(6):CD001833. doi: 10.1002/14651858.CD001833.pub3. Cochrane Database Syst Rev. 2014. PMID: 24954057 Free PMC article.